YOLFTbeta
Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler Strahlen- und Medizintechnik AG

0NZY · LSE

15.26EUR+1.06 (+7.46%)

Price History

Full chart

Market Stats

Previous Close14.20
Open14.32
Day Range13.60 – 15.26
52-Week Range12.04 – 17.95
Volume5.00K
Market Cap203.35M
P/E (TTM)0.30
Forward P/E0.00
EPS1.30
Dividend Yield1.41%
Beta1.47
50-Day Avg41.57
200-Day Avg46.57

About

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Company Details

  • CEODr. Harald Hasselmann
  • Employees1.10K
  • HeadquartersRobert-Rössle-Straße 10, Berlin, Germany, 13125, UK
  • Websitehttps://www.ezag.com

Leadership

  • Dr. Harald HasselmannCEO & Chairman of the Executive Board of Medical Segment · b. 1967
  • Dr. Gunnar MannCOO & Member of the Executive Board · b. 1967
  • Ms. Karolin RiehleHead of Investor Relations & PR
  • Mr. Joseph HathcockChief Operating Officer of Segment Isotope Products
  • Ivan SimmerManaging Director of Eckert & Ziegler Cesio s.r.o.
  • Mr. Julian SchröderHead of Group Controlling

Financials

Income Statement

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue31.22M29.20M35.53M41.79M50.38M54.44M71.61M101.40M111.09M116.20M120.00M117.14M127.26M139.75M119.87M138.63M168.71M178.49M176.14M180.44M222.23M246.09M295.85M311.96M
Growth (%)--6.47%+21.68%+17.61%+20.54%+8.07%+31.53%+41.59%+9.56%+4.59%+3.27%-2.38%+8.64%+9.82%-14.22%+15.65%+21.70%+5.80%-1.32%+2.44%+23.16%+10.74%+20.22%+5.45%
Cost of Revenue15.96M15.74M19.23M23.30M-23.90M27.58M37.45M50.27M53.30M51.78M54.81M60.06M63.47M76.88M60.27M74.77M94.23M91.47M89.61M89.36M115.48M129.75M152.69M158.98M
Gross Profit15.27M13.46M16.31M18.49M21.94M26.86M34.16M51.12M57.80M64.41M65.18M57.08M63.78M62.86M59.60M63.87M74.48M87.02M86.53M91.08M106.75M116.34M143.16M152.98M
Gross Margin48.90%46.08%45.89%44.25%43.56%49.34%47.70%50.42%52.03%55.43%54.32%48.72%50.12%44.98%49.72%46.07%44.14%48.75%49.13%50.48%48.04%47.28%48.39%49.04%
Operating Expense13.27M9.72M12.86M15.96M16.07M20.89M24.69M35.66M39.48M41.57M45.24M43.13M51.32M53.70M45.27M46.26M52.14M53.21M52.89M45.05M59.78M69.35M82.08M76.92M
Operating Income1.99M3.73M3.45M2.54M5.88M5.97M9.47M15.46M18.32M22.84M19.95M13.94M12.46M9.16M14.33M17.61M22.34M33.81M33.65M46.03M46.97M47.00M61.07M76.06M
Operating Margin6.38%12.78%9.71%6.07%11.67%10.97%13.22%15.25%16.49%19.66%16.62%11.90%9.80%6.56%11.95%12.70%13.24%18.94%19.10%25.51%21.14%19.10%20.64%24.38%
EBITDA6.25M7.42M7.31M6.45M10.15M9.48M18.69M28.01M26.71M30.63M27.29M20.82M19.38M17.33M21.43M25.88M30.78M40.92M40.17M39.75M54.34M57.26M77.38M89.53M
EBITDA Margin20.03%25.40%20.57%15.43%20.16%17.42%26.10%27.62%24.04%26.36%22.74%17.77%15.23%12.40%17.87%18.67%18.24%22.93%22.81%22.03%24.45%23.27%26.15%28.70%
Net Income346.00K-1.17M3.35M1.59M-2.15M3.04M21.89M10.41M10.42M10.29M9.04M6.78M11.66M10.21M11.60M16.13M22.02M21.29M34.53M30.89M26.30M33.28M48.76M
Net Income Margin1.11%-4.02%9.42%3.80%-3.95%4.24%21.59%9.38%8.97%8.58%7.71%5.32%8.35%8.52%8.37%9.56%12.34%12.09%19.14%13.90%10.69%11.25%15.63%
R&D3.43M670.00K350.00K512.00K215.00K134.00K3.11M2.50M2.89M3.00M3.45M4.87M3.62M4.04M3.11M3.32M3.81M3.75M3.38M3.78M3.17M4.33M4.86M5.10M
R&D as % of Total Revenue10.98%2.29%0.98%1.23%0.43%0.25%4.34%2.46%2.60%2.58%2.88%4.15%2.85%2.89%2.59%2.40%2.26%2.10%1.92%2.10%1.43%1.76%1.64%1.64%
Interest Expense176.00K236.00K359.00K716.00K-830.00K1.24M1.33M2.52M2.89M2.79M1.19M1.63M1.44M1.16M881.00K672.00K1.09M1.19M1.20M1.77M3.99M1.59M1.94M
Interest Expense % of Total Revenue0.56%0.81%1.01%1.71%-1.52%1.73%1.31%2.27%2.49%2.33%1.01%1.28%1.03%0.97%0.64%0.40%0.61%0.68%0.66%0.80%1.62%0.54%0.62%

Balance Sheet

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets49.73M45.71M48.96M67.00M64.17M67.59M98.80M161.90M144.47M154.04M164.44M178.41M187.33M196.68M199.47M216.99M229.05M274.24M289.44M347.73M407.46M439.36M442.40M457.93M
Total Liabilities16.80M16.89M16.31M32.04M28.27M31.45M55.98M75.25M70.86M72.47M77.47M88.14M92.84M92.01M89.39M99.47M105.17M134.79M143.08M155.20M193.83M215.27M217.18M204.50M
Total Equity32.93M28.81M32.65M34.76M35.91M36.14M42.82M76.41M68.31M75.88M80.73M83.49M88.58M99.69M105.19M112.34M122.64M138.19M145.26M187.39M212.07M222.18M223.45M251.77M
Cash6.14M8.94M5.50M4.95M4.68M4.38M7.31M43.67M29.22M32.30M30.84M29.41M21.82M31.47M36.57M57.71M54.19M78.92M87.47M93.66M82.70M68.00M118.22M128.69M
Total Debt4.00M4.29M2.58M12.75M--18.51M20.07M31.92M23.30M15.45M22.63M18.70M15.53M11.66M1.73M42.00K19.93M20.40M26.97M49.59M56.30M55.34M44.80M
Net Debt-2.13M-4.65M-2.92M7.80M-4.68M-4.38M11.20M-23.60M2.70M-9.01M-30.84M-29.41M-21.82M-31.47M-36.57M-57.71M-54.19M-58.99M-69.62M-69.75M-35.80M-14.29M-62.88M-83.88M

Cash Flow

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.01M4.15M2.56M3.53M6.92M8.29M8.57M22.11M15.03M20.16M16.57M14.68M10.65M16.23M19.83M26.83M21.21M40.43M34.95M33.85M34.30M37.70M66.57M58.41M
Investing Cash Flow-3.80M347.00K-5.72M-4.32M-2.67M-4.58M-5.46M-9.70M-7.54M-8.85M-11.35M-17.37M-10.81M972.00K-5.53M5.11M-10.70M-5.65M-11.51M-23.59M-41.04M-42.74M-16.59M-25.93M
Financing Cash Flow-1.45M-1.63M-251.00K25.00K-1.95M-2.20M-254.00K23.99M-22.28M-8.41M-6.59M1.65M-8.55M-8.42M-9.52M-9.96M-14.60M-10.50M-12.96M-6.06M-5.71M-9.28M-9.99M-19.53M
Capital Expenditure2.70M1.53M3.23M3.68M005.98M5.69M5.78M9.18M9.83M9.65M7.82M3.84M5.33M4.16M6.12M7.25M7.07M28.86M31.13M26.28M17.19M26.02M
Free Cash Flow4.31M2.62M-672.00K-146.00K6.92M8.29M2.58M16.42M9.25M10.98M6.74M5.03M2.84M12.39M14.50M22.67M15.09M33.17M27.88M5.00M3.17M11.42M49.38M32.39M
Dividends Paid1.46M--775.00K--786.00K1.13M2.33M3.17M3.17M3.17M3.17M3.17M3.17M3.49M4.13M6.18M8.75M9.32M10.38M10.41M1.04M10.43M
FCF to OCF61.48%63.07%-26.26%-4.13%100.00%100.00%30.14%74.25%61.54%54.45%40.68%34.24%26.64%76.32%73.11%84.49%71.13%82.06%79.78%14.77%9.24%30.29%74.17%55.45%
Dividend Paid to FCF33.90%---530.82%--30.44%6.89%25.25%28.91%47.06%63.14%111.80%25.62%21.88%15.40%27.38%18.62%31.39%186.46%327.71%91.12%2.11%32.20%

Earnings

Report DateSep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 22, 2024May 14, 2024Aug 9, 2024Nov 14, 2024Dec 31, 2024May 12, 2025Aug 8, 2025Nov 13, 2025Mar 26, 2026May 12, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate--------------------------------------------------------------------
EPS Actual0.030.170.040.040.040.030.060.050.030.030.040.050.030.050.040.040.040.030.030.040.020.040.080.020.030.040.030.040.030.060.090.040.040.040.100.070.050.090.120.090.050.080.120.080.080.220.140.110.080.100.140.130.100.080.100.150.290.410.460.260.160.460.190.130.300.170.19-
Surprise--------------------------------------------------------------------
Timing--------------------------------------------------------Pre-marketAfter-hoursPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap203.35M
Enterprise Value726.78M
Trailing P/E0.30
Forward P/E0.00
Price / Sales0.65
Price / Book0.00
EPS1.30
Book Value4.30
Revenue (TTM)312.50M
Gross Profit (TTM)152.24M
EBITDA88.66M
Profit Margin15.92%
Operating Margin22.71%
Return on Equity20.14%
Return on Assets10.30%
Shares Outstanding5.06M
Shares Float42.79M
Beta1.47
Dividend Yield1.41%
Dividend Rate0.00
Payout Ratio27.80%

Dividends

20261×
0.22Jun 25, 2026
20251×
0.17Jun 19, 2025
20241×
0.01Jun 27, 2024
20231×
0.15Jun 8, 2023
20221×
0.15Jun 2, 2022
20211×
0.13Jun 3, 2021
20201×
0.13Jun 11, 2020
20191×
0.09May 30, 2019
20181×
0.06May 31, 2018
20171×
0.00Jun 1, 2017
20161×
0.04Jun 9, 2016
20151×
0.04Jun 4, 2015
20141×
0.04May 23, 2014
20131×
0.04May 20, 2013
20121×
0.04May 25, 2012
20111×
0.04May 20, 2011
20101×
0.03May 21, 2010

Stock Splits

  • Aug 13, 2025959692:319897
  • Jul 31, 20204:1
  • Nov 19, 2009903:845